(Q51066747)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Angela Cioffi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Angela Cioffi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Yves-Marie Robin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Nicolas Penel

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

2

Axel Le Cesne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

3

Isabelle Ray-Coquard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

10

Stéphanie Clisant

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

7

Nicolas Isambert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1

Christine Chevreau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

13

Emmanuelle Bompas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

11

Loic Chaigneau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Antoine Italiano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Charles Fournier

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Eric Gauthier

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jacques-Olivier Bay

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

15 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

2639-2644

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

The evolving classification of soft tissue tumours: an update based on the new WHO classification

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Appraising the current role of chemotherapy for the treatment of sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Angiosarcoma: state of the art and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

Bevacizumab for recurrent hemangioendothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

7 January 2021

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

7 January 2021

Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

7 January 2021

Randomized discontinuation design: application to cytostatic antineoplastic agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28109

7 January 2021

Identifiers

DOI

10.1002/CNCR.28109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json

release_4ds2lknpejfepiyoasj2kkzhym

28 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4ds2lknpejfepiyoasj2kkzhym

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589078%20AND%20SRC:MED&resulttype=core&format=json